whatshot

CRIS   $0.8  -0.55% Market Closed

Curis Inc
show_chart Advanced Chart of CRIS
Last Events:

2023-03-30 Trend pattern changed from восходящий треугольник to расходящийся клин с наклоном вниз.

2023-03-30 Signal in Stochastic changed from bearish to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-03-30 Signal in MACD changed from bearish reversal to bullish reversal. Oscillator MACD is in the negative territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the end of the downward trend. Last signal: main and signal line crossing.

2023-03-30 Signal in RSI changed from bullish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-03-30 Signal in EMA100 changed from n/a to bearish reversal. 2023-02-06 the price crossed down the moving average line and demonstrates a downside trend.

2023-03-30 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-03-07 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-03-30 Trend Power changed from strong to .

2023-03-29 Trend pattern changed from расходящийся клин с наклоном вниз to восходящий треугольник.

Current temperature: 1.48
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.71
Target: 6.75
High with 50% probability: 1.75
Analyst Recommendations:
Number of estimates 4
Target Price Mean 6.75
Mean unverified/preliminary 6.75 / 6.75
Target Price Low / High 3.00 / 10.00
Median / STD DEV 7.00 / 3.30
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell - -
stoch - - -
ma20 Sell Sell -
ma50 - - -
ma100 Sell Sell -
Candlestick PatternApril 17, 2023 Deliberation Block Formation - consists of three black bodies with consecutively lower closes in a downtrend. The final day is a short black candlestick, a spinning top or a doji. Considered to be a bullish reversal pattern.
ISIN US2312692005
ceo Mr. James E. Dentzer
Website https://www.curis.com
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreement with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed four programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.